Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
The Chief Judge of the U.S. Court of Appeals for the Federal Circuit (CAFC), Kimberly Moore, on Monday authored a short ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
The Federal Circuit reinstated a challenge of a Merck KGaA unit’s pigment patent by South Korea-based CQV Co. on Monday, ...
The US Patent Trial and Appeal Board handed a massive victory to Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) on Wednesday, ...
Background: ImmunoGen’s Patent Application & Dispute - In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
The Federal Circuit upheld an administrative tribunal’s ruling nixing 29 of 31 claims from a gesture-recognition patent ...
A federal court has ruled in Apple's favor in the years-long fight against AliveCor, preventing a potential total import ban ...
Plenty of patent examiners at the U.S. Patent and Trademark Office (USPTO) have standards of patentability that are higher ...
Apple and health technology company AliveCor have been embroiled in multiple legal battles for years, including a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results